Feedback and Notes


Imagine No Religion

Latest Activity

Chris commented on Stephen's group A Woman's right to choose
1 hour ago
Chris replied to Chris's discussion Death by religious upbringing
3 hours ago
Chris replied to Chris's discussion Death by religious upbringing
4 hours ago
Chris replied to Chris's discussion Death by religious upbringing
4 hours ago
Chris replied to Chris's discussion Death by religious upbringing
4 hours ago
Chris left a comment for Joey Daniel Smith
5 hours ago
Joey Daniel Smith posted a status
"Are you out there Chris?"
6 hours ago
Chris replied to D L's discussion Have the rich and powerful lost their altruistic instincts?
6 hours ago
Joey Daniel Smith replied to Chris's discussion Death by religious upbringing
6 hours ago
Joey Daniel Smith replied to Chris's discussion Death by religious upbringing
6 hours ago
Chris replied to Chris's discussion Death by religious upbringing
6 hours ago
Joey Daniel Smith replied to Chris's discussion Death by religious upbringing
7 hours ago
Joey Daniel Smith replied to Chris's discussion Death by religious upbringing
7 hours ago
Chris commented on Lester Unega Waya's video
7 hours ago
Joey Daniel Smith replied to Chris's discussion Death by religious upbringing
8 hours ago
Stephen left a comment for Tanner Barker
11 hours ago
Stephen left a comment for Md. Hashebur Rahman
11 hours ago
Stephen left a comment for Matttammar
11 hours ago
Stephen left a comment for Dexter Lee
11 hours ago
Stephen commented on Doone has Fremdschämen's group World History
12 hours ago

We are a worldwide social network of freethinkers, atheists, agnostics and secular humanists.

Medicine, Medical insurance Pharmaceuticals, and Medical Care (CDC and etcetera)


Medicine, Medical insurance Pharmaceuticals, and Medical Care (CDC and etcetera)

This is a group to discuss the problems with Medicine, Medical insurance, pharmacieuticals, and Medical Care, CDC (Center for Disease Control), Medicins Sans Frontieres (Doctors Without Boarders), and etcetra.

Members: 9
Latest Activity: Jan 26

Discussion Forum

This group does not have any discussions yet.

Comment Wall

Nice Comment

You need to be a member of Medicine, Medical insurance Pharmaceuticals, and Medical Care (CDC and etcetera) to add comments!

Comment by Chris on November 21, 2016 at 12:00pm

Dietary Supplements can be beneficial to your health — but taking supplements can also involve health risks.

Because dietary supplements are under the "umbrella" of foods, FDA's Center for Food Safety and Applied Nutrition (CFSAN) is responsible for the agency's oversight of these products. The Dietary Supplement Health and Education Act (DSHEA) of 1994, which amended the Federal Food, Drug, and Cosmetic Act, created a new regulatory framework for the safety and labeling of dietary supplements. FDA is not authorized to review dietary supplement products for saf...

The following are resources and important information for you and your family about dietary supplements.

More in the link above.

Holding homeopathis drugs to the same standard as other OTC is a worthless gesture.

For example there are over the counter supplements that contain vitamin C and Zink marketed to shorten the lengh of colds  There is no scientific evidence that it helps.

Glucosamine and Chondrotin is marketed to help with joint pain.

Both of the above are at best placebo.s

The Federal Trade Comission is for marketing, not for medicine. Snake oil companies from the 1800's aren't much different than they are today except maybe they can't sell strychnine as vitamine D.

I wonder if lipstick no longer contains lead under the cosmetic act.

Are lipsticks dangerous?

Every day millions of women apply lipstick without a second thought. What many don't know is that lipsticks may contain lead, the notorious metal that can cause learning, language and behavioral problems. Lead is a neurotoxin and can be dangerous even at small doses.
So what's lead doing in lipsticks?
Not all lipsticks contain lead, but a number of studies in recent years show that the metal is more prevalent than previously thought.
In 2007, the Campaign for Safe Cosmetics conducted a study -- "A Poison Kiss" -- that detected lead in 61% of the 33 lipsticks tested, with levels ranging from 0.03 ppm to 0.65 ppm. Parts per million (ppm) is the measurement of lead in the environment.
More in the lipstick link above.
According to CNN it's okay to put lead in lipstick perhaps it's also okay to put strychnine in vitamin supplements.
Way to go Federal Trade Comission.
Junk bonds forever as long as companies make money.
Comment by Chris on November 20, 2016 at 11:22pm

Fake news?

Homeopathy: The Ultimate Fake
Stephen Barrett, M.D.

Homeopathic "remedies" enjoy a unique status in the health marketplace: They are the only category of quack products legally marketable as drugs. This situation is the result of two circumstances. First, the 1938 Federal Food, Drug, and Cosmetic Act, which was shepherded through Congress by a homeopathic physician who was a senator, recognizes as drugs all substances included in the Homeopathic Pharmacopeia of the United States. Second, the FDA has not held homeopathic products to the same standards as other drugs. Today they are marketed in health-food stores, in pharmacies, in practitioner offices, by multilevel distributors, through the mail, and on the Internet.

Basic Misbeliefs

Samuel Hahnemann (1755-1843), a German physician, began formulating homeopathy's basic principles in the late 1700s. Hahnemann was justifiably distressed about bloodletting, leeching, purging, and other medical procedures of his day that did far more harm than good. Thinking that these treatments were intended to "balance the body's 'humors' by opposite effects," he developed his "law of similars"—a notion that symptoms of disease can be cured by extremely small amounts of substances that produce similar symptoms in healthy people when administered in large amounts. The word "homeopathy" is derived from the Greek words homoios (similar) and pathos (suffering or disease).

Hahnemann and his early followers conducted "provings" in which they administered herbs, minerals, and other substances to healthy people, including themselves, and kept detailed records of what they observed. Later these records were compiled into lengthy reference books called materia medica, which are used to match a patient's symptoms with a "corresponding" drug.

Hahnemann declared that diseases represent a disturbance in the body's ability to heal itself and that only a small stimulus is needed to begin the healing process. He also claimed that chronic diseases were manifestations of a suppressed itch (psora), a kind of miasma or evil spirit. At first he used small doses of accepted medications. But later he used enormous dilutions and theorized that the smaller the dose, the more powerful the effect—a notion commonly referred to as the "law of infinitesimals." That, of course, is just the opposite of the dose-response relationship that pharmacologists have demonstrated.

The basis for inclusion in the Homeopathic Pharmacopeia is not modern scientific testing, but homeopathic "provings" conducted during the 1800s and early 1900s. The current (ninth) edition describes how more than a thousand substances are prepared for homeopathic use. It does not identify the symptoms or diseases for which homeopathic products should be used; that is decided by the practitioner (or manufacturer). The fact that substances listed in the Homeopathic Pharmacopeia are legally recognized as "drugs" does not mean that either the law or the FDA recognizes them as effective.

More is available through the link at the top of this post.

Comment by Stephen on November 20, 2016 at 6:57pm

A new ruling finally requires homeopathic 'treatments' to obey the same labeling standards as real medicines

The Federal Trade Commission issued a statement this month which said that homeopathic remedies have to be held to the same standard as other products that make similar claims. In other words, American companies must now have reliable scientific evidence for health-related claims that their products can treat specific conditions and illnesses. 

Read more=

Comment by Chris on November 12, 2016 at 5:55am

Most new drugs are incredibly expensive.  Sometimes they have advantages but sometimes the added expense can ruin someone's life.

Not only the monetary cost  often the side effects of new pharmacuticals  make them less worthy than medicine tha'ts been around for a long time and has been 'tested'  proven valiuable and effective.

Comment by Chris on November 12, 2016 at 5:41am

How twising information becomes. Here's a report about the Hepatitis C drug Sovaldi embeded in TPP.

The Final Bill for TPP May Include Trump
WSJ: Obama Makes a Long-Shot Bid for TPP Trade Deal
In the final days of the campaign, President Obama was still pushing the TPP deal (Wall Street Journal, 11/1/16)...

However, even against this backdrop, the election was still incredibly close, with states like Wisconsin, Pennsylvania and Michigan certainly well within Clinton’s reach. There were many factors that depressed Clinton’s vote, most obviously the endless drumbeat about emails, which were amplified in the last days of the campaign by FBI Director James Comey’s bizarre intervention into the race.

While many of these factors were beyond the control of Clinton and the Democrats, one factor that was under their control was the decision to push the Trans-Pacific Partnership (TPP). Needless to say, there is little public knowledge of the details of the TPP. But the TPP symbolized a pattern of trade that cost millions of manufacturing jobs in the prior decade, and put downward pressure on the wages of the workers without college degrees more generally.

EPI: Productivity vs. Compensation
Source: Economic Policy Institute, based on Bureau of Labor Statistics and Bureau of Economic Analysis data

This pattern of trade has been an important factor in the wage stagnation of the last four decades. If the wages of workers without college degrees had kept pace with productivity growth since 1980, they would be more than 40 percent higher than they are today. This is a big deal to these workers and their families. Even if trade was not the whole story of income inequality, working class people are certainly correct to see it as a big part of the picture.

The TPP probably would not have substantially contributed, at least directly, to further depressing wages. We already have trade deals with six of the 11 countries in the pact, and have extensive trade relations with the others. Rather, the TPP was about putting in place a business-friendly structure of regulation. It also increased patent and copyright protection, with the goal of increasing the profits of the pharmaceutical, software and entertainment industries. In other words, the TPP was about further extending a pattern of trade aimed at redistributing income upward.

It is important to understand that this is not some natural process of globalization. We deliberately placed our manufacturing workers in direct competition with low-paid workers in the developing world. The predicted and actual effect of this policy is to lower their wages. At the same time, we have left in place or even increased protections that benefit those at the high end. Our doctors earn on average more than $250,000 a year, twice the pay of their counterparts in other wealthy countries. This gap is in large part because we prohibit foreign doctors from practicing in the United States unless they complete a US residency program. There is a similar story of protectionism for dentists who must graduate a US dental school (or, recently, Canadian).

In addition, making patents and copyrights longer and stronger, both here and around the world, redistributes income from the bulk of the population to those in a position to profit from these protections. This is the story of the Hepatitis C drug Sovaldi, which has a list price of $84,000. The free market price is a couple hundred dollars. We will pay more than $430 billion this year for drugs that would sell for 10–20 percent of this amount in a free market.

There was nothing natural about the upward redistribution we have seen over the last four decades; it was deliberate policy. And the TPP was a symbol of this policy. It was a trade pact that was crafted by and for major business interests.

Comment by Chris on November 12, 2016 at 4:54am

We all know this 'don't we?'

As drug industry’s influence over research grows, so does the poten...

November 24, 2012

For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup.

The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.

“We now have clear evidence from a large international study that the initial use of [Avandia] is more effective than standard therapies,” a senior vice president of GlaxoSmithKline, Lawson Macartney, said in a news release.

What only careful readers of the article would have gleaned is the extent of the financial connections between the drugmaker and the research. The trial had been funded by GlaxoSmithKline, and each of the 11 authors had received money from the company. Four were employees and held company stock. The other seven were academic experts who had received grants or consultant fees from the firm.

Whether these ties altered the report on Avandia may be impossible for readers to know. But while sorting through the data from more than 4,000 patients, the investigators missed hints of a danger that, when fully realized four years later, would lead to Avandia’s virtual disappearance from the United States:

More in the above link including a graphic.

Comment by Chris on November 10, 2016 at 9:59pm

The FDA, equivalent of NICE has been gutted through deregulation and budget cuts in the U.S.A.. The Fox guards the hen house.

Comment by Stephen on November 10, 2016 at 9:19pm

If you allow it the drug company's would charge anything they could get away with.

In the UK we have an independent org called NICE (The National Institute for Health and Care Excellence) that makes a scientific and rational decision weather the NHS will buy any new drugs. not just on price but also on the effectiveness of the new drugs.

Comment by Chris on November 9, 2016 at 11:23am

FDA Concludes that Invokana Increases Risk of Osteoporosis

In addition to kidney damage, ketoacidosis and heart attacks, it turns out that canagliflozin – sold under the brand names Invokana and Invokamet – increases the risks of osteoporosis, or loss of bone density.

In clinical studies, elderly Type-2 diabetics treated with Invokana for two years or more showed reduced bone density in their lower spines and hips. While many people lose bone density as they get older, the recent studies show that treatment with Invokana can greatly accelerate the process. Some patients can suffer fractures in as little as three months after starting on the medication. Risks of bone loss and fractures were most pronounced in post-menopausal women.

The study, part of a post-marketing safety evaluation, continued for two years and involved more than 700 geriatric patients. According to a statement from the Food and Drug Administration (FDA) issued on September 10th, “The additional data confirm the finding that fractures occur more frequently with canagliflozin [Invokana] than placebo…fractures can occur as early as 12 weeks after starting the drug.”  Additional data was gathered from nine other clinical trials in which test subjects took the drug for an average of 85 weeks.

As a result of this new data, stronger warnings will be added to Invokana prescribing information.  The FDA is advising physicians to consider the risk of bone fractures before prescribing Invokana for their diabetic patients. In addition to Invokana, the FDA is monitoring similar medications in the class of SLGT2 inhibitors, or gliflozins.  These prescription drugs target a specific protein, known as sodium/glucose co-transporter 2. This protein is involved in the reabsorption of blood sugar (glucose) in the kidneys. SLGT2 inhibitors allow excess glucose to be passed in the urine. In addition to kidney damage, these drugs also increase the risk of urinary tract infections, vaginal yeast infections and dangerously low blood sugar levels (hypoglycemia). Other drugs in the gliflozin class include Farxiga (dapagliflozin), Jardiance (empagliflozin) and Glyxambia (linagliptin). All of these drugs will be under FDA scrutiny over the next several months.

Comment by Chris on November 9, 2016 at 11:20am

Silent Killer: Blood Thinner With No Antidote May Be Responsible fo...

For years Warfarin was the gold standard of blood thinners. Then the pharmaceutical industry saw an opportunity to make a profit by introducing new products. The products would promise the same or improved effectiveness with less hassle. Enter Xarelto, a blood thinner and anticoagulant that promises results with less administrative complication. The problem is that Xarelto has no antidote and patients may be dying because of it.

“Pharmaceutical companies, regrettably, have shown a tendency to put their own profits ahead of patient safety,” commented Ned McWilliams, a partner with the Levin Papantonio law firm. The Levin, Papantonio law firm is leading investigations into claims of injuries resulting from Xarelto.

Part of the marketing pitch for physicians to choose Xarelto over Warfarin hinges on the lower oversight requirements supposedly carried by the drug. According to the manufacturer, patients taking Xarelto require less surveillance by a physician. The argument is that Warfarin required constant monitoring to ensure that the levels of the drug in the patient’s blood didn’t get out of control.

If the saturation did get out of control though, often the only treatment that was necessary was to give patients a dose of Vitamin K to encourage clotting. Xarelto has no antidote. The manufacturer has yet to issue instructions to physicians about how to combat the problem of uncontrolled bleeding when it presents in patients as a result of Xarelto.

That problem of uncontrollable bleeding is what has patient advocates in arms over Xarelto. The product wasn’t needed; it solved a problem that didn’t need fixing. It has no antidote. The company that makes it has yet to publish guidelines for treating some of the most serious complications for treating the deadly side effects. And the company is making millions from the drug’s continued sale in the United States.

The only thing that can be done to treat an overdose of Xarelto, at this time, is to issue fresh plasma to the patient or wait for the drug to clear the blood. When the complication a patient is suffering from is hemorrhage or internal bleeding, that lack of an antidote may prove life-threatening.

Joshua is a writer and researcher with Ring of Fire. You can follow him on Twitter @Joshual33.


Members (9)


© 2018   Created by Atheist Universe.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service